Dana-Farber Cancer Institute - Chestnut Hill — Newton, Massachusetts

Dana-Farber Cancer Institute - Chestnut Hill is a clinical research site located in Newton, Massachusetts, United States 02459.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute - Chestnut Hill has participated in 17 clinical trials with 13 currently active.

Therapeutic areas: Breast Cancer, Non-small Cell Lung Cancer, Advanced/Metastatic Solid Tumors.

Sponsors: Pfizer, ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute - Chestnut Hill?

Dana-Farber Cancer Institute - Chestnut Hill has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute - Chestnut Hill conducted?

Dana-Farber Cancer Institute - Chestnut Hill has 17 clinical trials on record, with 13 currently active. Their work covers Breast Cancer, Non-small Cell Lung Cancer, Advanced/Metastatic Solid Tumors.

Is Dana-Farber Cancer Institute - Chestnut Hill accredited by Crixeo Health?

Yes — Dana-Farber Cancer Institute - Chestnut Hill holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dana-Farber Cancer Institute - Chestnut Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.